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 A REPORTS
 Dendritic Cells Exposed to Human
 Immunodeficiency Virus Type-i Transmit a
 Vigorous Cytopathic Infection to CD4+ T Cells
 Paul U. Cameron, Peter S. Freudenthal, Jeanne M. Barker,
 Stuart Gezelter, Kayo Inaba, Ralph M. Steinman*
 The paucity of virus-laden CD4+ cells in individuals infected with human immunodeficiency
 virus type-1 (HIV-1) contrasts with the greatly reduced numbers and function of these
 lymphocytes. A pathway is described whereby dendritic cells carry HIV-1 to uninfected T
 cells, amplifying the cytopathic effects of small amounts of virus. After exposure to HIV-1,
 dendritic cells continue to present superantigens and antigens, forming clusters with T cells
 that are driven to replicate. Infection of the dendritic cells cannot be detected, but the
 clustered T cells form syncytia, release virions, and die. Carnage of HIV-1 by dendritic cells
 may facilitate the lysis and loss of antigen specific CD4+ T cells in acquired immunode-
 ficiency syndrome.
 The critical loss of CD4+ T lymphocytes
 that follows infection with human HIV-1
 depletes cells that defend against opportu-
 nistic infections (1). Whereas HIV-1 is
 cytopathic for CD4+ T cells in culture (2,
 3), the number of HIV-1-infected lympho-
 cytes in patients is small, 1% of the total or
 much less (4-9). The paucity of infected T
 cells has stimulated experiments to look for
 autoimmune and other mechanisms that
 eliminate CD4+ lymphocytes. An altema-
 tive possibility is that antigen-presenting
 cells (APCs) that have been exposed to
 HIV-1 m'ediate the lysis of uninfected-
 CD4+ T cells that are responding to anti-
 gens in the presence of small amounts of
 virus. Here we show that the trace popula-
 tion of antigen-presenting dendritic cells
 represents such a catalyst. The APCs are
 exposed to HIV-1, washed, and added to T
 cells that are then stimulated with a super-
 antigen or an antigen. An explosive cyto-
 pathic infection in the responding T cells
 ensues even though the dendritic cells
 themselves are not productively infected.
 Dendritic cells are a widely distributed
 system of APCs [reviewed in (10)]. Al-
 though few in number, these can be en-
 riched from several human tissues including
 blood, inflammatory exudates, thymus,
 lung, skin, gut, and tonsil. In each in-
 stance, the dendritic cells have a character-
 istic stellate shape and motility, high levels
 of adhesion molecules and antigen-present-
 ing major histocompatibility complex
 (MHC) class II products, and potent acces-
 sory function for a variety of T cel'l-depen-
 dent responses. For example, in the primary
 mixed leukocyte reaction, or in the primary
 response to superantigens, small numbers of
 dendritic cells stimulate T cells to undergo
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 extensive proliferation (11-13). During
 these events, the dendritic cells and re-
 sponding T cells form discrete aggregates
 that represent the microenvironment for
 the immune response (11, 14). Because
 stimulated rather than resting T cells are
 the principal targets for a cytopathic infec-
 tion with HIV-1 (3, 15), the microenviron-
 ment that is created by dendritic cells
 would in the presence of virus seem omi-
 nous for those T cells that are attempting to
 respond.
 An improved enrichment procedure for
 human blood dendritic cells was recently
 described (12). A combination of markers
 that selectively identify other cell types (for
 example, CD3, CD14, and CD19 for T
 cells, monocytes, and B cells, respectively)
 was used to negatively select the trace den-
 dritic cell subset in a fluorescence-activated
 cell sorter (12, 16). In addition to typical
 morphology and motility, the enriched den-
 dritic cells had high levels of class II MHC
 products and low levels of CD4. The ab-
 sence of CD2, at3 T cell receptor (TCR),
 CD3, CD4, and CD8 indicated a virtual
 absence of contaminating T cells.
 To test whether dendritic cells were high-
 ly susceptible to HIV-1 infection as suggest-
 ed (17-19), we used polymerase chain reac-
 tion (PCR) to quantitate reverse transcripts
 in APCs relative to positive controls, which
 were stimulated CD4+ lymphocytes or "T
 blasts" (20-23). After exposure to HIV-1
 (24), T blasts rapidly transcribed proviral
 DNA (Fig. IA). Within 6 hours, high
 concentrations of full-length provirus were
 evident with gag-specific primers [SK68 and
 SK69 (21)1. In contrast, the purified den-
 dritic cells did not contain provirus at 6 or
 12 hours (Fig. IA), nor were early tran-
 scripts detected with long terminal repeat
 (LTR) primers (see below).
 In experiments, which are illustrated
 with the HTLV-IIIB isolate in Fig. 1B, the
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 Fig. 1. Dendritic cells, purified by fluores-
 cence-activated cell sorting and pulsed with
 HIV-1, do not become infected but can trans-
 mit an infection to T cells activated by super-
 antigens. (A) Different cell populations (leg-
 end) were pulsed with HTLV-11IB at a multiplic-
 ity of infection of 0.5 for 1.5 hours at 3700.
 Control cells were pulsed with heat-inactivat-
 ed HIV-1 (HI-HIV-1). The cells were washed
 and recultured in complete medium. The cells
 were harvested 0, 6, and 12 hours later, and
 DNA was prepared for PCR of gag-specific
 sequences (primers SK38 and SK39). Lane 1,
 sorted dendritic cells; lane 2, B + NK cells
 [metrizamide high-density cells]; lane 3, T
 blasts; and lane 4, CD4+ T cells. The controls
 were ACH-2 cells diluted in uninfected Er+ T
 cells; 6, 104 ; 5, 103 ; 4, 102 ; 3, 101; 2, 1; and 1,
 0 ACH-2 cells per milliliter. (B) Dendritic cells
 (104), monocytes, or T cells that had been
 pulsed with HTLV-IIIB (or several other iso-
 lates) (24) were cultured in round-bottom 96-
 well plates without (left panel) or with (right
 panel) 105 T cells plus superantigen (SEE, 5
 ng/ml). Culture supernatants were harvested
 every other day and assayed for RT (25). In
 ber o cels weemntoe_n thePC
 were~ ~ no xoe octkne rohrsiui
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 HIV-1-pulsed dendritic cells that were in-
 capable of producing reverse transcriptase
 (RT) (25, 26) did transmit an infection to
 stimulated T cells. As stimulant, we used
 the superantigen staphylococcal enterotox-
 in E (SEE), which acts by binding to MHC
 class II molecules on the APC and specific
 V, segments of the T cell receptor for
 antigen (27). Several different isolates of
 HIV-1 including monocytotropic strains
 were tested with similar results. In the
 cultures that were stimulated by HIV-1-
 pulsed dendritic cells, numerous syncytia
 and trypan blue-positive dead cells were
 noted by days 3 and 5 of the dendritic
 cell-T cell coculture, respectively. At sim-
 ilar doses to dendritic cells, virus-pulsed
 monocytes and T cells (Er' cells) were
 ineffective in transmitting a productive in-
 fection (Fig. iB), indicating the impor-
 tance of presenting the HIV-1 in associa-
 tion with dendritic cell APCs. If resting T
 cells were pulsed with virus and then added
 to dendritic cells, RT activity was weak or
 absent in spite of strong T cell proliferation.
 It was necessary to pulse the dendritic cells
 at 37?C versus 4?C for these APCs to
 transmit HIV-1. No RT was produced, and
 T cells did not proliferate if SEE was added
 in the absence of APCs. Therefore, it seems
 necessary to pulse the dendritic cells with
 HIV-1 to initiate proliferation and produc-
 tive infection in resting T cells.
 The rapid course of the infection in
 Fig. 1B (RT detectable between days 3 and
 5 and peaking between days 5 and 7)
 suggested that infection of dendritic cells
 was not a prerequisite for transmission to
 T cells. Nonetheless, it was conceivable
 that dendritic cells would become permis-
 sive to HIV-1 in the same way that CD4+
 T cells become permissive after lympho-
 cyte activation (3, 15). Because it is
 known that murine CD4+ T cells do not
 permit entry of HIV-1 (28), we developed
 a strategy with xenogeneic coculture to
 substantiate that virus-pulsed dendritic
 cells did not become infected during their
 interaction with CD4+ cells. At appropri-
 ate concentrations of SEE, we found that
 dendritic cells induced comparable prolif-
 eration of homologous and xenogeneic
 CD4+ T cells. Therefore various mixtures
 (human or mouse dendritic cells with
 either mouse or human CD4+ T cells)
 were exposed to virus at 0, 24, and 48
 hours after initiation of coculture. Six hours
 after adding HIV- 1, DNA was extracted for
 PCR analysis of late (gag) and early LTR
 reverse transcripts. Few gag-specific se-
 quences occurred in any of the cultures
 pulsed at time 0 (Fig. 2A). When the
 CD4+ T cells were of human origin, there
 were increasing numbers of gag target se-
 quences in cultures pulsed after 24 or 48
 hours. In contrast, murine or human den-
 dritic cells in culture with murine CD4+ T
 cells showed little if any such increase in
 PCR signal (Fig. 2A, lanes 2 and 4).
 These data on gag transcripts did not
 exclude the possibility that viral entry into
 dendritic cells may have occurred but with-
 out appropriate signals for efficient transcrip-
 tion of gag-containing retrovirus. Therefore,
 cocultures were also examined for early tran-
 scripts with LTR-specific primers. Quiescent
 human CD4+ T cells (Fig. 2B, time 0, lanes
 1 and 3) contained many copies of early
 transcripts, confirming previous work (15).
 During activation (48-hour time point)
 there was no further increase in LTR tran-
 scripts. NQ early or late transcripts were
 noted in the human dendritic cell-contain-
 ing cultures (Fig. 2, A and B).
 The experiments were carried out in
 another way. HIV-1-pulsed murine or hu-
 man dendritic cells were added to murine or
 human CD4+ T cells in all four possible
 combinations. Virus production was as-
 sessed by RT and p24 (Fig. 2, C and D).
 Virus was produced only in cultures con-
 taining T cells of human origin. Both mu-
 rine and human dendritic cells transmitted
 infection to human CD4+ T cells. To
 substantiate that dendritic cell infection
 with HIV-1 was not necessary for transmis-
 sion, we added azidothymidine (AZT) to
 block any infection of dendritic cells that
 might occur during exposure to HIV-1. In
 control experiments, AZT (10 ,uM) did
 block the infection of HIV-1-pulsed T
 blasts. However, AZT-treated virus-pulsed
 dendritic cells transmitted the infection to
 superantigen-stimulated CD4+ T cells.
 We then used the mixed leukocyte reac-
 tion (MLR) to test if virus-pulsed dendritic
 cells would transmit HIV-1 to antigen-
 responsive T cells. In the MLR, antigens on
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 Fig. 2. Xenogeneic mixtures of dendritic cells and CD4+ T cells replicate HIV-1 only when human
 CD4+ T cells are present. In (A) and (B), the cultures contained 3 x 104 dendritic cells and 5 x 104
 (human) or 105 (murine) CD4+ cells in round-bottom microtiter plates. The controls were graded
 doses of ACH-2 cells (lane 1, 0 ACH-2 cells per milliliter; lane 2, 10 cells; lane 3, 102; lane 4, 103;
 and lane 5, 104). In (C) and (D), 104 human or mouse dendritic cells were pulsed with HIV-1 or
 heat-inactivated HIV-1 (HI-HIV-1) and added to triplicate cultures of xenogeneic or allogeneic CD4+
 cells (105 human or 2 x 105 murine; flat-bottom microtiter plates), and superantigen was added
 (final SEE of 100 pg/ml human/human; 1 ng/ml mouse/mouse and mouse/human; and 5 ng/mI
 human/mouse). (A) Cultures were pulsed with HIV-1 at the indicated times, and 6 hours later cellular
 DNA was isolated and amplified for full length reverse transcripts (gag primers). Lane 1, human
 dendritic cells (DC)/human CD4; lane 2, human DC/mouse CD4; lane 3, mouse DC/human CD4;
 and lane 4, mouse DC/mouse CD4. (B) As in (A), but the DNA was amplified for early transcripts
 (LTR primers). (C) RT activity in culture supernatants measured daily for 5 days. Hu, human; Mu,
 murine. (D) HIV p24 antigen quantitated by enzyme-linked immunoabsorbant assay (ELISA) at 5
 days. OD, optical density; H, human; M, mouse.
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 I REPORTS
 dendritic cells from one individual vigor-
 ously stimulate T cells from another indi-
 vidual to proliferate, produce lymphokines,
 and form killer T cells (11, 12, 14, 29). We
 noted that HIV-1-pulsed dendritic cells
 were fully active as MLR stimulators at least
 at the early time points, days 2 to 4. At
 later time points, when T cell cytotoxicity
 was manifest (below), DNA synthesis in
 response to HIV-1-pulsed dendritic cells
 was reduced 50% or more relative to con-
 trols. When HIV-1 infection was moni-
 tored with standard assays for RT, the use of
 virus-pulsed dendritic cells led to a vigorous
 infection that was dependent on the dose of
 APCs (Fig. 3A). RT was detectable at day
 3 of the MLR with a dendritic-T cell ratio
 of 1:30, and at day 5 with a ratio of 1:100.
 Syngeneic APC-T cell mixtures exhibited
 little or no DNA synthesis and no release of
 RT (Fig. 3A).
 In any one individual, only a minor
 fraction of T cells respond to antigens on
 another individual's dendritic cells. To
 monitor the development of a cytopathic
 infection more directly, we isolated the
 clusters of interacting dendritic cells and T
 cells that characteristically develop in an
 MLR (11). The clustered cells represented
 <5% of the cells in the culture and prolif-
 erated vigorously (Fig. 3B). If the dendritic
 cells had been pulsed with live HIV-1, the
 clusters generated a cytopathic infection
 with release of RT and cell death (Fig. 3, C
 and D). Nonclustered cells did not prolif-
 erate or show evidence of infection (Fig. 3,
 B, C, and D).
 By electron microscopy (Fig. 4A, ar-
 rows), the clusters contained T blasts and
 dendritic cells, the latter extending numer-
 ous and characteristic sheet-like processes.
 Budding of HIV-1 was evident only on
 lymphocytes, but not on the extensive
 sheets of dendritic cell surface (Fig. 4B).
 To assess whether dendritic cells were
 themselves becoming infected during the
 MLR, we used an assay described by Lifson
 et al. (30). Cells that are productively
 infected with HIV-1, if labeled with a
 fluorescent dye, transfer the dye to unin-
 fected CD4+ T cells. Dye transfer is the
 result of the syncytium formation that oc-
 curs when HIV envelope proteins on one
 cell fuse with CD4 on another. If dendritic
 cells were productively infected with HIV-
 1, the expressed gp 120/41 should result in
 their fusion with the many closely apposed
 CD4+ T blasts and syncytia in the MLR
 clusters. In control studies, we found that
 dendritic cells that were tagged with two
 different fluorescent dyes stimulated the
 MLR in an identical fashion to untreated
 dendritic cells although now the discrete
 dye-labeled APCs in the clusters could be
 observed. When pulsed with HIV-1, the
 dye-labeled dendritic cells did not fuse with
 the syncytia (Fig. 4, C and D). As a
 positive control we noted that dye-labeled,
 HIV-1-infected T blasts delivered the dye
 to the syncytia that were numerous in our
 MLR cultures.
 Our results differ from a report that the
 APC function of dendritic cells is ablated
 after exposure to the HTLV-IIIB strain
 (31). Perhaps the HIV-1 preparation used
 in previous studies contained other suppres-
 sants or APC function was measured at
 later time points after T cell cytopathicity
 had begun. The capacity of HIV-1-pulsed
 dendritic cells to function normally as
 APCs must underlie our findings. The abil-
 ity of these APCs to create long-lived ag-
 gregates of responding T blasts creates an
 environment in which one would expect an
 infection of even one T cell to be rapidly
 transmitted through syncytium formation
 or virus production to the other activated
 cells in the cluster. Indeed, syncytia can be
 observed in most of the clusters that devel-
 op when lymphocytes respond to antigen or
 superantigen on dendritic cells.
 Our results also differ from reports sug-
 A B * Clusters+ HI-HIV-1
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 Fig. 3. Transmission of HIV-1 from virus-pulsed dend;itic cells to CD4+ T cells responding in the
 MLR. (A) Time course of RT activity in MLR cultures in which graded doses of dendritic cells were
 added to a constant dose of 105 CD4+ allogeneic (Allo, closed symbols) or syngeneic (Syn, open
 symbols) lymphocytes. The data are mean c u ts per minute per microliter of culture medium
 (triplicates). No RT was detected in culture wh re the dendritic cells were pulsed with HI-HIV-1. (B)
 Dendritic cell-CD4+ T lymphocyte clusters are he focus of the immune response in the MLR.
 Clusters of interacting cells were sepa a ed from 24-hour MLR cultures that had been set up in
 24-well plates with 5 x 104 dendritic cells and 1.5 x 106 CD4+ T cells in 1 ml of medium. Clusters
 were isolated by applying six to ten cultures to 1-g columns made of 5 ml of RPMI-1640
 supplemented with 40% fetal calf serum in 15-ml conical tubes. The clusters were allowed to settle
 to the bottom of the tube for 1 to 1.5 hours on ice and the nonclustered cells were removed from the
 top. The fractions were cultured separately in microtiter wells, clusters at 3 x 104 per well and
 nonclusters at 1.5 x 105 per well. We measured DNA synthesis by the uptake of 3H-thymidine
 (added for 8 hours at 1 p,Ci per well; 6 Ci/mM where 1 Ci = 37 GBq). (C) RT (assays on 1 ,u of
 culture supernatant) is generated from clustered T cells in the MLR. (D) Loss of cell viability (trypan
 blue-positive and -negative cells) in the clustered fraction in the MLR. Nonclustered cells from
 infected and control cultures showed no significant change in cell numbers.
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 Fig. 4. Morphologic assays demonstrate that dendritic cells are not productively infected with HIV-1
 during their interaction with responding CD4+ T cells. (A) Low-power electro  microscopic view
 showing T blasts (T) and many dendritic cell processes (DC, arrows) in cell clusters isolated at day
 3 of a primary MLR, x9750. (B) Higher magnification of the boxed area in (A) to demonstrate viral
 budding (arrows) from lymphocytes but not from dendritic cells whose processes are abundant,
 x32,500. (C and D) Dendritic cells labeled with a fluorescent dye do not fuse with HIV-1-induced
 syncytia. The dendritic cells were labeled with the fluorescent PKH2 dye [(C); Zynaxis (Malvern,
 Pennsylvania) 5 pg/ml for 3 to 4 min in Hanks basic salt solution (HBSS) at room temperature] or the
 dill carbocyanine dye [(D); Molecular Probes, Eugene, Orego ; 20 jxg/ml of HBSS for 30 min at
 370C]. The labeling was stopped by adding an equal volume of fetal calf serum and washing twice
 with complete medium. The MLR between dye-labeled dendritic cells and unlabeled allogeneic
 CD4+ T cells was observed daily in a Nikon inverted stage microscope equipped with epifluores-
 cence. For the higher power observations shown here, the cells were spun at 900 rpm for 2 min onto
 glass slides in a Shandon cytocentrifuge and photographed immediately without fixatio . The
 fluorescence micrograph is superimposed o  the phase contrast icrograph of a dendritic-T cell
 cluster. Many brightly fluorescent (white) dendritic cells are juxtaposed wit  large syncytia (white
 arrows), but there is no fusion or transfer of dye from the APCs to the T cells.
 gesting that blood dendritic cells are readily
 infected by HTLV-IIIB (17-19). The lack
 of infection may be attributed to the pau-
 city of CD4 molecules on dendritic cells, so
 that other populations with higher concen-
 trations of CD4 such as the epidermal
 Langerhans cells are in need of study.
 Nonetheless, our findings emphasize anoth-
 er feature of dendritic cell function: to act
 as a catalyst in the transmission of a cyto-
 pathic infection. The efficiency of virus
 transmission from virus-pulsed dendritic
 cells to T cells suggests a synthesis between
 our report and earlier publications. We
 enriched human dendritic cells by cell sort-
 ing and monitored the extent of T cell
 depletion by cytofluorography, whereas the
 populations that were used in other reports
 may have contained contaminating T cells
 that were further stimulated with exoge-
 nous lymphokines (18). Also the PCR and
 dye-labeling approaches hat we used (Fig.
 4) provide direct and quantitative means
 for showing that efficient reverse transcrip-
 tion of HIV-1 and virus budding did not
 occur in either resting or stimulated human
 blood dendritic cells. Transmission through
 dendritic cells is more efficient than
 through other APCs (Fig. IB). This may be
 attributable to the potency of dendritic cells
 in activating large numbers of CD4+ T cells
 (11, 32).
 In situ, mucosal and airway dendritic
 cells may carry and present virus to re-
 sponding T cells at the same time as the T
 cells are activated by other environmental
 antigens carried by the dendritic cells. An
 analogous mechanism may operate in the
 germinal centers of lymphoid organs. Here
 B cells may be presenting antigens to CD4+
 T cells in the presence of a reservoir of
 HIV-1-bearing follicular dendritic cells (9,
 10, 33). The latter differ from the bone
 marrow-derived dendritic cells that we
 have studied, but in both instances exten-
 sive losses of antigen-specific, previously
 uninfected T cells result from the transmis-
 sion of HIV-1 that is carried by APCs.
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 Negative Inotropic Effects of Cytokines on the
 Heart Mediated by Nitric Oxide
 Mitchell S. Finkel,* Carmine V. Oddis, Timothy D. Jacob,
 Simon C. Watkins, Brack G. Hattler, Richard L. Simmons
 The direct effects of pro-inflammatory cytokines on the contractility of mammalian heart
 were studied. Tumor necrosis factor a, interleukin-6, and interleukin-2 inhibited contractility
 of isolated hamster papillary muscles in a concentration-dependent, reversible manner.
 The nitric oxide synthase inhibitor NG_monomethyl-L-arginine (L-NMMA) blocked these
 negative inotropic effects. L-Arginine reversed the inhibition by L-NMMA. Removal of the
 endocardial endothelium did not alter these responses. These findings demonstrate that
 the direct negative inotropic effect of cytokines is mediated through a myocardial nitric oxide
 synthase. The regulation of pro-inflammatory cytokines and myocardial nitric oxide syn-
 thase may provide new therapeutic strategies for the treatment of cardiac disease.
 Pro-inflammatory cytokines are a class of
 secretory polypeptides that are synthesized
 and released locally by macrophages, leuko-
 cytes, and endothelial cells in response to
 injury (1-4). Reperfusion of ischemic myo-
 cardium is associated with the infiltration
 by leukocytes and macrophages that may be
 responsible for a transient depression of
 myocardial contractility ("stunned myocar-
 dium") (5-9). This report attempts to de-
 termine if pro-inflammatory cytokines pro-
 duce direct reversible inotropic effects in
 isolated papillary muscle preparations.
 The addition of recombinant human
 tumor necrosis factor ac (TNF-ac) and inter-
 leukin-6 and interleukin-2 (IL-6 and IL-2)
 to the medium bathing isolated papillary
 muscles resulted in a concentration-depen-
 dent, reversible negative inotropic effect
 (Fig. 1). The negative inotropic effects
 were observed within 2 to 3 min, were
 maximal after 5 min, remained constant for
at least 20 min, and were completely re-
 versed within 40 min after the cytokines
 were removed from the bath. Recombinant
 human IL-lot had little inotropic effect.
 Concentration response curves were
 generated for each of the cytokines (Fig. 2).
TNF-ac demonstrated a negative inotropic
 effect in a concentration range from 150 to
 3200 U/ml. The majority of the effect was
 observed at concentrations below 900 U/ml
 (59 + 7% and 44 + 3% of baseline tension
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 Fig. 1. Photographs of rep- A C
 resentative chart record-
 ings illustrating the effects
 of adding increasing con-
 centrations of cytokines on
 tension generated at 1 Hz Baseline lSo soo 900 1800 3200 Washout Baseline 1 s 15 60 160 1000lWashout
 by isolated papillary mus- ITNF-x] (U/mi) [IL-2] (U/mI)
 cles prepared from
 4-month-old F B control B D
 Syrian hamsters (Bio-
 breeders Inc., Fitchburg, f
 Massachusetts) (19). Vig- l .|
 orously beating hearts Baseline 150 500 900 1800 3200 Washout Baseline 150 500 900 1800 3200
 were removed and placed [IL 6J (U/mi) [IL 1 aJ (U/mi)
 in oxygenated Tyrode's so-
 lution containing 130 mM NaCI, 4.7 mM KCI, 20 mM NaHCO3, 1.2 mM NaH2PO4, 2.5 mM CaCI2, 1.2
 mM MgSO4, and 5.6 mM glucose oxygenated with 95% 02 and 5% CO2 (pH 7.4 at 250C). Left
 ventricular papillary muscles were excised and attached at one end to a pressure transducer in a
 bath (5 ml) containing the same Tyrode's solution with bovine serum albumin (1 %) oxygenated with
 95% 02 and 5% CO2 warmed to 370C (pH 7.4). Papillary muscles were stimulated at twice the
 threshold voltage with bipolar platinum electrodes and the tension generated was recorded with a
 Gould model 3400 recorder with built-in dc bridge preamplifier and transducer. We administered
 recombinant human cytokines (Genzyme, Cambridge, Masschusetts) by pipetting portions (50 ,ul)
 directly into the tissue bath, and then the medium was replaced with continuous perfusions of
 Tyrode's solution alone at 7.5 ml/min for 30 min; 150 to 3200 U/ml of TNF-aL (A), 150 to 3200 U/ml
 of IL-6 (B), 1 to 1000 U/ml of IL-2 (C), 150 to 3200 U/ml of IL-1-ao (D).
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